We analyzed the inter-user variability of patient setup for prostate radiotherapy using a stereotactic ultrasound-targeting device. Setup variations in 20 prostate cancer patients were analyzed. Users were a radiation oncologist, a medical physicist, four radiation technologists (RTT) and a radiologist. The radiation oncologist, radiologist. physicist and two RTTs were experienced users of the system (>18 months of experience); two RTTs were users new to the system. Gold standard for this analysis was a control CT acquired immediately following ultrasound targeting. For inter-user variability assessments, the radiation oncologist provided a set of axial and sagittal freeze-frames (standard freeze-frames) for virtual targeting by all users. Additionally each user acquired individual freeze-frames for target alignments. We analyzed the range of virtual setups in each patient along the principal room axes based on standard and individual freeze-frames. The magnitude of residual setup error and percentage of setup change for each user was assessed by control CT/planning CT comparison with individual virtual shifts. A total of 184 alignments were analyzed. The range of virtual shifts between users was 2.7±1.4, 3.6±1.1, and 4.4±1.4 mm (mean±SD) in x, y and z-direction for setups based on standard freeze-frames and 3.9±2.6, 6.0±4.7, and 5.4±2.7 mm for setups based on individual freeze-frames. When only virtual shifts of experienced users were analyzed, the mean ranges were reduced by up to 2.4 mm.
Introduction
Daily stereotactic ultrasound targeting was developed to facilitate reliable patient setup for external beam radiotherapy of prostate cancer. The commercially available systems allow for the superimposition of anatomical contours derived from treatment planning CT onto real-time ultrasound images in treatment position. Subsequently, couch/patient shifts in the principal room directions, required to precisely position the target for radiation treatment, are indicated. Upon implementation of the technology, data on the feasibility of daily use and accuracy of the systems have been reported (2, 6, 7.9, 12, 13) .
Various users such as radiation oncologists, medical physicists, and, most often, radiation therapy technologists typically use these ultrasound-targeting systems. Prior exposure to ultrasound imaging technology varies widely between these user groups and common guidelines for training and standardized procedures for implementation of these systems do not exist. It seems reasonable to assume that interindividual performance and, thus, setup quality might vary between users. However, no peer-reviewed data regarding a systematic study of the inter-user variability of resulting patient setup are available. As of today it remains unclear if the degree of inter-user variability would be large enough to warrant analysis of its potential clinical impact with regard to dose deposition and resulting probability of tumor control and normal tissue toxicity. Serago et al. performed a comparison study to assess the intra-observer accuracy by comparing two back-to-back ultrasound setups by the same ultrasound operator and found that setups were reproducible within 3 mm at a 95% confidence level. If a second operator performed the comparison setup, the reproducibility was within 3 mm at an 80 to 90% confidence level (12) . While the authors derived a system intrinsic uncertainty of 3 mrn, dependency on individual operators or sets of operators was acknowledged but not specifically studied. Most recently, three presentations, published in abstract form, have raised concerns about the range of inter-user variability and the ability of such systems to improve on patient setup (3, 5, 14) .
This study aimed to systematically assess inter-user variability of patient setup. We attempted to identify potential system and user related sources of random and systematic errors associated with failure to achieve an appropriate patient setup.
Methods and Material
This study was conducted as a quality control assessment of reliability of inter-user patient setup using a stereotactic ultrasound system (BAT, Nomos Corp., Sewickley, PA) . . Data collection and analysis have been approved by the Institutional Review Board under IRB # E-023-021.
Study Design: Patients and User Profiles
Between June 2002 and November 2002, 20 prostate cancer patients were analyzed with regard to the quality of BAT derived individual setup and variability of resulting setups between various users of the system.
The group of users for this study consisted of a radiation oncologist, a radiologist, a medical physicist and four radiation technologists (RTT). Of the four RTTs, two were experienced users with a minimum of 18 months of experience in clinical use of the system (average 20 ultrasound patient setups per day) and two were new users of the system with Fuss et at. experiences ranging from days to weeks of use. Presence of the radiation oncologist, at least one experienced RTT (participation in 18 and 20 studies) and the radiologist was required for any given day of the study. The other users participated on 12 (physicist), 8, and 9 (RTTs) study days, resulting in a median number of 5 users (4 to 7) per study day.
Ultrasound Targeting Using the BAT System
Details regarding daily stereotactic ultrasound alignment using the BAT'system have been reported (6, 7. 9) . No technical modifications to the system have been made.
In brief, prior to BAT ultrasound targeting, the patient is positioned on the treatment table in supine position, using room-laser alignment to skin marks. Ultrasound images are acquired in both axial and sagittal planes. Target (prostate and seminal vesicle where appropriate) and organ at risk (bladder and rectum) contours, derived from CT-based treatment planning, are superimposed onto the ultrasound images and possible misalignments can be assessed. The system allows for a virtual shift of the CT derived structure outlines, until a best match to the actual organ outlines in the ultrasound freeze-frames is achieved. The BAT system then indicates treatment couch shifts in all three principal room axes (left/right, up/down, in/out) that are required to align the patient in the correct position relative to the radiation beam geometry for delivery of the respective radiation fraction.
Study Design: Technical Considerations
Ultrasound alignments were conducted after the patient's radiation treatment on a study day, with the patient in treatment position on the CT simulator couch and aligned to room lasers according to tattooed skin marks. For the purpose of stereotactic ultrasound targeting and alignment in the CT simulation suite, the BAT device was calibrated to the isocenter of the imaging plane of the CT scanner.
Following a typical daily ultrasound alignment procedure, the BAT study for the respective patient was accessed electronically, the ultrasound probe registered to the isocenter of the CT simulator by attaching it to a cradle affixed to the front fascia of the CT scanner, and ultrasound freeze-frame images were acquired in nominally axial and sagittal planes.
For stage I of the study, a single set of axial and sagittal freeze-frames was provided for all users by the radiation oncologist. This was defined as a 'standard freeze-frame'. Every user performed a virtual patient alignment by use of the software inherent directional arrows until a supposedly optimal alignment between ultrasound freeze-frames and CT derived contours was achieved. The resulting virtual shifts were entered into a database, but not executed, to provide identical conditions for each user. Subsequently, all virtual shifts were returned to zero and the next user performed a virtual alignment. No user was permitted to observe the alignment of a previous user. After the last virtual alignment, BBs were placed at the skin marks to indicate the intersection of the room lasers on the patient's surface and a control CT with scan parameters identical to the planning CT was acquired (i.e. identical field of view and slice thickness).
In stage 2 of the study, in addition to the standard freezeframes alignments of stage I, all users present acquired their own individual freeze-frames of the prostate in 15 of the 20 patients. Virtual shifts were performed and recorded and the individual freeze-frames and individual alignment data were stored. In similar technique as previously described, a control CT was performed.
Data Analysis
Recorded virtual shifts were entered into an Excel spreadsheet. Statistical data analysis was performed using SPSS 11.0 software (SPSS Inc., Chicago, IL).
For each individual patient the range or spread of virtual shifts along the three principal axes was analyzed in alignments based on standard freeze-frames and individually acquired freeze frames. In order to detect the impact of experience in use of the system on the range of resulting setups, a subset analysis was conducted excluding data of the two relatively inexperienced RTTs.
The control CT was compared with the treatment planning CT in order to assess the magnitude of prostate setup errors (initial setup error), as a surrogate for setup error if a treatment would have been performed after alignment of skin marks to room lasers. The dislocation in the three principal room directions was assessed using an in-house developed iterative root-mean-square (RMS) optimization-fitting algorithm (10). The algorithm calculated, through 3D rigid body mechanics, the displacement of the prostate in the control CT relative to the treatment planning CT. The dislocation in the three principal room directions was then correlated with individual virtual shifts as derived from the ultrasound targeting system. The difference of the virtual BAT shift and the setup error assessed between the CT studies allowed for calculation of the individual residual setup error.
The magnitude of the 3D vector of initial prostate setup error was determined from the CT/CT comparison and correlated with the 3D magnitude vector of individual residual setup error to determine if individual shifts would have benefited the patient by better positioning the prostate or, alternatively, led to the introduction of new, larger setup errors. Improvement or impairment was expressed as percent change from initial setup misalignment. Percentages of change were T-tested between groups of experienced and inexperienced users.
Results
One hundred eighty four virtual BAT alignments were available for analysis with 106 virtual alignments based on standard freeze-fames and 78 virtual alignments based on individually acquired freeze-fames, respectively. The larger number of virtual alignments based on standard freezeframes was related to the fact that in the initial four patients only such alignments were performed. One additional patient asked to interrupt the study after standard freezeframe alignments were acquired. Figure I represents four individually acquired axial and sagittal freeze-frames for one of the patients in the present study (alignments were performed by experienced users only).
Inter User Variability: Range of Virtual Shifts in Standard Freeze-frames
The mean range of virtual shifts between users in left/right, up/down and in/out-direction was 2.7±1.4, 3.6±1.1, and 4A±1.4 mm (mean±SD). For individual patients, these ranges were as small as 0.6 mm left/right, 1.8 mm up/down and 0.9 mm in in/out direction while maximum ranges of 5.9 mm left/right, 5.7 mm up/down and 7.3 mm in in/out direction were observed.
Inter User Variability: Range of Virtual Shifts in Individually Acquired Freeze-frames
The mean range of virtual shifts between users in left/right, up/down and in/out-direction was 3.9±2.6, 6.0±4.7, and 5A±2.7 mrn, respectively. For individual patients, these ranges were as small as 1.0 mm left/right, 0.8 mm up/down and 2.1 mm in in/out direction while maximum ranges of 9.7 mm left/right, 20.2 mm up/down and 13.1 mm in in/out direction were observed.
Training Impact on Range ofInter-user Variability of Virtual Shifts
If only the range of virtual shifts of personnel that had significant exposure to the use of the BAT device and the radiologist were analyzed, notable reductions were observed. The average range in left/right, up/down, and in/out direction was 2A±I.2, 3.3±1.1, and 4.1±IA rnrn, and 3.5±2.5, 4A±2A, and 4.8±1.8 based on standard and individual freeze-frames. respectively. The maximal range of shifts based on standard and individual freeze-frames was observed to be 5.1, 5.7, and 7.1 mm and 8.0, 804, and 8.1 mm in the respective principal directions. The reduction in maximal shift range by experienced personnel varied between°mm and 11.8 mm when compared with data representing all users. While left/right reduction in shift range was rather nominal, the observed reduction in range in up/down and in/out direction indicated the impact of experience in use of the system.
Evaluation of the Accuracy of BAT Indicated Shifts
The difference in prostate position in the original treatment planning CT and the repeat CT dataset were correlated with the virtual BAT shifts for assessment of the residual setup error. The absolute difference in the principal room axes was entered into a database. Mean residual setup errors for the radiologist (which was always the last user to perform a virtual shift) in left/right direction were 1.l±1.0 mm, up/down 1.6±1.l mm, and in/out 2.6±1.7 mm, respectively. The single largest observed residual setup error for this user was 3.7, 4.6, and 6.0 mm in left/right, up/down and in/out direction, respectively. The length of the average magnitude 3D vector of residual setup error was 3.6±1.7 mm (range 1.2 to 6.6 mm).
Assessment of the Inter-user Variability in Residual Setup Error and Improvement/Impairment of Prostate Setup
Individual user magnitude 3D vector of residual setup error was computed for all setups performed and compared with the magnitude vector of initial setup error (Figure 2 and 3) . The average magnitude of initial setup error was 14.3±5.0 mm. 17 of 20 patients displayed an initial setup error larger than 10 mm and the minimal and maximal magnitude of initial setup error was 6.1 and 23.3 mm, respectively. Following BAT ultrasound targeting, all but 9 of 184 virtual alignments would have reduced the residual setup error to be below 10 mm and the median magnitude of residual setup error would have been 4.3 mm. Five of 184 virtual setups (2.7%) would have introduced a setup error larger than the initial setup error achieved by aligning the patient to room lasers and skin marks. The average added error for these three setups would have been 3.2 mm (range 0.2 to 9.5 mm). Figure 4 displays the average percentage of setup improvement by user. If grouped by experienced and inexperienced user, the differences in degree of setup improvement were significantly different (p<O.OOOI). Experienced users achieved on average a 63.1±23.4'7'0 setup error reduction, and inexperienced users reduced initial setup errors by 35.4±36.7'7'0, respectively. The frequencies of percent reduction in setup errors for all users and grouped for experienced and inexperienced users are displayed in Figure 5 . While inexperienced user setup showed significantly less improvement than setups performed by experienced users, more than 88% of their setups would have benefited the individual patient by reducing the initial setup error.
T-testing the distribution of residual setup errors along the principal axes against zero revealed no clinically relevant systematic difference. While cranio-caudally, a numeric difference of Fuss et al. 0.9 mm was computed to be statistically significant at p=0.043, this difference was within the resolution of the imaging system, which was specified as being 2 mm by the manufacturer.
Discussion
Daily control of target volume position and appropriate correction for any misalignment is desirable for tumors that require radiation treatment doses exceeding the tolerances of adjacent structures. Outcomes after radiation treatment for prostate cancer have been significantly improved by increasing radiation doses, but have been associated with increased rates of acute and late side effects when measures such as rectal shielding or repeated daily CT for setup control are not employed (4, 7, 8, 11) . The location of the prostate immediately inferior to the bladder and anteriorly to the rectum may cause dose exposure to a significant portion of those organs when the prostate position varies during the course of radiation.
Stereotactic ultrasound targeting for prostate cancer radiotherapy relies on identifying prostate, bladder and rectum by their outline and separating tissues such as fat layer and/or peritoneal fold. Under ideal circumstances, the prostate can be visualized by these ultrasound systems from base to apex and the rectum and bladder can be clearly discriminated from the target organ. However, several circumstances might prohibit straightforward. ideal prostate targeting. Increased body size and subcutaneous fat layers, as well as variable filling status of the bladder might complicate, or even prohibit ideal visualization by essentially any ultrasound imaging system. Secondly, ultrasound targeting relies on an anatomically correct delineation of prostate and organs at risk during the treatment planning process. If the outlines, as derived from the treatment planning software, are not representative of the organs' outlines in ultrasound imaging, the accuracy and reproducibility of such alignments will be compromised.
The primary source of system related errors, that is a calibration error of the system leading to a systematic misrepresentation of the radiation beam geometry and thus systematic setup shifts, can be avoided by implementation of a brief daily QA procedure in which an ultrasound phantom with known geometry is utilized to verify correct spatial calibration of the system. Thus, calibration errors as a potential source of errors in inter-observer variability studies as described by van den Heuvel et al. (15) can be effectively avoided.
Inter-user variability of ultrasound targeting setup is certain-Iy a critical issue in light of the fact that personnel, typically lacking formal training in ultrasound, are expected to perform such a patient setup and alignment under challenging time constraints common to most radiation oncology treatment suites. The fact that, besides vendor support, application-tailored formal training programs by a professional association Technology in CancerResearch &Treatment, Volume 2, Number2, April 2003 or independent institutes are lacking, does not contribute to the establishment of a common knowledge base.
anterior/posterior direction, the frequency of errors in the superior/inferior direction may be increased (5) , This study also observed a considerable amount of inter-user variability. It may come as no surprise, therefore, that studies recently presented in abstract format, assessing the inter-user variability upon initial implementation of this technology, have come to the conclusion that there is currently no reason to believe that the use of BAT would warrant a reduction in safety margins applied for day to day organ movement and setup error (15) . A second group of investigators have come to the conclusion that while the use of the BAT system significantly reduced the frequency of positioning errors in the The present study differs from these two studies in that it assessed, primarily, inter-user variability of personnel that had at least 18 months of experience using the BAT system clinically. In order to assess the impact of user experience and, thus, training, a separate group of users new to the system was also evaluated. A second difference from previous studies regards the fact that setup in the present study was directly correlated with CT data sets acquired by the CT sim- Figure 5 : Frequencies of observed reduction in magnitude of initial setup error in percent for all users and grouped for experienced and inexperienced users. The curves represent the derived Gaussian distribution for this normally distributed data, Percent reduction of initial setup errors are higher and the normal distribution indicates smaller standard deviation, and thus more consistent and of higher benefit for the patients, if experienced users attempted patient setup by ultrasound targeting. ulator with imaging parameters identical to those used for the treatment planning simulation, versus comparing resulting BAT alignments with implanted fiducial marker positional assessment in perpendicular electronic portal imaging (EPID). Thus, potential inter-user positional assessment errors experienced when employing an EPID system, as documented by a group of investigators that also studied the BAT inter-user variability (I), can be excluded as an additional source of uncertainty in our study.
The present study documents that use of ultrasound targeting systems almost always improves a patient's treatment setup. Average setup error reductions of 63% and 35% achieved by experienced and inexperienced users establish, that such systems yield immediate positive impact on patient setup. Even users relatively new to the system do improve upon patient setups on a regular basis as evidenced by the fact that all but three of their virtual setups in the present study would have benefited the patients. Training and experience will, no doubt, further improve on the quality of this group's resulting prostate alignments. We have chosen to analyze the magnitude 3D vector of residual setup error rather than focusing on the documented range of setup errors in any principal room direction. This approach yields not only the most important dimension, the absolute distance in a 3D space by which the prostate is off its designated treatment position, it also takes into account the fact that alignments that vary along one room axis between users might still all benefit the resulting patient setup. While a range of setup variations along one room axis might provide interesting information, it fails to provide information regarding the true remaining prostate setup error. If the true prostate position falls, by chance, between the maximal positions of a given range, each of the most disagreeing users is in error from the correct position by the same absolute distance.
The data derived from the present study confirm, that training improves on the inter-user variability by excluding the most erroneous setup errors. We identified several sources for such potential setup errors:
I)
Alignments failing to align CT derived organ outlines accurately with anatomical structures as displayed in the ultrasound freeze frame:
Such errors were identified as clear training issues and occurred predominantly in personnel relatively unfamiliar in interpreting ultrasound images. Besides random, erroneous virtual alignments that occurred along all room axes, possibly the most critical error that occurred was erroneous identification of the tissue separation between prostate and bladder. Subsequently, anatomically incorrect virtual alignment of the antero-cranial aspect of the prostate to the fluid/tissue border in the bladder resulted. Those alignments ignored the fact that the bladder floor can almost always be clearly distin-guished from the prostate itself in ultrasound imaging. Such alignment errors may have critical consequences, in that they may introduce new systematic setup errors. While the bladder floor thickness varies with bladder filling over a course of treatment, prostate cancer patients typically show an increasingly limited filling volume in the bladder, rendering the bladder floor between 4 and 6 mm thick. Thus, alignments to the fluid/tissue intersection may introduce systematic errors of the same dimension, predominantly in the in/out direction.
It may be reasonable to speculate that introduction of new systematic setup errors in the referenced abstracts might be partially caused by such alignment routines.
2)
Target and organ at risk delineation on CT failing to represent the real anatomy:
We identified target delineations, which followed a clinical target volume/planning target volume (CTV/PTV) concept, rather than delineating the anatomical organ volume, to be the cause of significant problems. In sueh situations, misalignments are typically caused by the fact that a "best guess" alignment of an anatomically too large CT-derived contour, with an anatomically correct, smaller ultrasound representation of the prostate volume, must be performed.
Since most often the RTTs, rather than the physicians, perform the alignment, and communication regarding target volume concepts is typically absent, these alignments will not become more accurate over time.
An additional source of potential errors related to the definition of target volumes might be the random inclusion or exclusion of the bladder floor into the prostate volume. This is complicated by the fact that the separation of the two stru~ tures might not always be defined with reasonable certainty in CT planning imaging sets due to the finite thickness of the axially oriented CT slices. During this study we recognized that the radiation oncologist, medical physicist and RTTs, but not the radiologist, were inclined to split the difference between real prostate and fluid/tissue line in recognition of the factthat the true dimensions of the organs based on CT contours might be somewhat variable, and that such a strategy could minimize resulting setup errors. However, the radiologist based her alignments on strict anatomical interpretation and the assumption that all CT-derived contours represented the anatomical boundaries. She typically aligned the CT-derived contour representing the bladder-prostate interface precisely onto the ultrasound image separation between bladder and prostate, thus systematically aligning differently from all other users in the study. This was represented in the collected data by the fact, that initially, the largest difference in any room axes was observed in the cranio-caudal setup between all users and the radiologist (data not shown). Since communication and training was part of the present study, this issue was rapidly recognized and a consensus alignment strategy was developed. Subsequently all CT-derived organ volumes for BAT assisted IMRT treatment were controlled and optimized not to include the bladder floor, and all ensuing alignments were agreed to follow the true anatomical separation between bladder and prostate.
A strategy to standardize this organ delineation issue could be, to consistently include the bladder floor into the prostate volume, and to deliberately use the easily appreciated fluid/tissue border for alignments. This may reduce setup errors but must take into account the fact that the planning CT simulation should not be conducted with significant bladder filling. Otherwise, a stretched out bladder floor might be as thin as 2 mm and during the course of radiotherapy systematic setup errors with increasing thickness due to emptier bladder will occur.
If a CTV/PTV target concept is desired, a so-called "BAT study" based on a copy of the same CT data set but with anatomically accurately outlined organs can be created. The disadvantage of this approach might be that target and organ at risk volumes in these second data sets must be modified (a time concern for the busy physician), and that the actual dose distribution cannot always be superimposed onto the ultrasound freeze-frames (in some inverse treatment planning systems, a dose calculation based on these modified volumes has to be performed in order to export the structure set to the ultrasound targeting system).
3)
Ultrasound prostate alignment by targeting the seminal vesicles rendered highly unreliable and variable setups:
Minor changes in rectal and bladder filling may change the positionof the seminal vesicles relative to the prostate position significantly. In fact, in our earlier experience, alignments to the seminal vesicles have been related with prostate setup errors as large as 10 mm in the anterior/posterior direction. Seminal vesicle dislocation follows a systematic pattern with anterior flexion by a filled rectum and posterior inferior flexion, due to a full bladder. Thus, strategiesto perform the treatment simulation with mid to low bladder fillingand empty rectum might again reduce, but not exclude, setup errors resulting from such alignments. The range of errors of alignments to the seminal vesicles is not represented in the present data, since one of the established guidelines at our institution is to avoid such setups. It is highly likely that the range of setups, and resulting magnitude of residual setup error would have been significantly larger if one or two users had performed such alignments based on their individual freeze-frames.
The datacollected duringthe presentstudyindicate thatthe range of setupsalongthe principal roomaxes,as wellas resulting magnitude of residual setup error, and thus, the inter-user variability
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are smaller when all users aligned on the same ultrasound freezeframes as provided for thestandard freeze-frame partof thestudy. Those freeze-frames were acquired by the radiation oncologist with the specific intent of providing as close to an ideal representation of the prostate as possible in the two imaging planes. An increase in inter-user variability was observed when each user had to acquireindividual freeze-frames.
Alignments on a provided set of freeze-frames and individual alignment comparisonsoccur on a regular basis in clinical routine on the treatment machine. During the initial training phase, an experienced user typically provides a good set of freeze-frames and has the new user perform a virtualalignment on these images. Upon identification of structures that should be present in a quality freeze-frame, new users begin acquiring their own images for alignments. While consistentstrategiesto acquire freeze-frames and to align CT derived structure sets to the ultrasound images might not prohibit systematic enol'S per se, they may enable the identification of such errors and the establishmentof guidelines to reduce their occurrence,
The residual setuperrors in the presentstudy comparefavorably with earlierreporteddata by Lattanzi et al. whichquantified the mean residual error following BATalignment as ranging from 2.4 to 4.6 mm (6, 7) . Comparison of these two studiesconfirms that such excellentlevelsof setuperror reduction cannot only be achieved by a single institution but might realistically represent the capabilityof the tested ultrasound targeting system.
While from the data gathered in the present study, no definitive recommendation can be made as to the timeframe required to gain the necessary expertise to perform ultrasound targeting reliably with high patient benefits, we believe that a time-frame of 3 to 6 months, or roughly 20 completed treatment courses, should provide the needed exposure. In our experience, involvement of a physician trained in ultrasound imaging was very helpful in identifying organ borders, and providing strategies to more reliably accomplish alignments that any observer would agree to. This benefit could, most likely, also be accomplished through the involvement of an ultrasonographer. Given current reimbursement levels for ultrasound targeting, this does not seem unreasonable.
An interesting question remains. Does the remaining variability in patient setup warrant further investigation as to the dose deposition and resulting estimation of tumor control and normal tissue toxicity probability. In our opinion the answer is ambiguous. The remaining setup error falls within the assigned safety margins as defined in our institution (between 8 and 10 mm) and as such might suggest that from a purely clinical standpoint such investigation is not necessarily warranted. However, in a currently ongoing investigation we attempt to determine the dosimetric consequences if the stated and smaller safety margins are used.
. Technology in CancerResearch & Treatment, Volume 2, Number2, April 2003 The present data support the following conclusions: Stereotactic ultrasound targeting for daily radiotherapy alignment of prostate cancer can be performed with a high interuser consistency and significantly reduces treatment setup errors for radiotherapy of prostate cancer. This statement applies especially to trained personnel. The inter-user variability as assessed in the present study remains slightly larger than the variations observed between two ultrasound operators in the Mayo Clinic study (12) . This finding is certainly expected and can be interpreted as a typical range of user performance in any radiotherapy department or clinic. We propose that a consistent approach to delineation of prostate and organs at risk and subsequent common targeting strategy, in combination with a comprehensive and effective training program can render the BAT ultrasound targeting system a highly effective tool in the treatment of prostate cancer.
